Clinical Report: Evaluating the Diagnostic Efficacy of 18 F-FDG PET-CT

Overview

This study assesses the diagnostic efficacy of 18 F-FDG PET-CT combined with ultrasound-guided core needle biopsy for primary gastrointestinal lymphoma (PGIL) patients. The findings suggest that this combined approach enhances diagnostic accuracy while minimizing invasiveness.

Background

Primary gastrointestinal lymphomas (PGILs) represent a significant subset of extranodal lymphomas, necessitating accurate and timely diagnosis for effective treatment. Traditional biopsy methods often fall short, leading to unnecessary surgeries and delayed chemotherapy. The integration of advanced imaging techniques like 18 F-FDG PET-CT with minimally invasive biopsy methods could improve diagnostic outcomes and patient management.

Data Highlights

No numerical data provided in the source material.

Key Findings

• PGILs account for 30%-45% of extranodal lymphomas and 5%-20% of all non-Hodgkin’s lymphomas.
• Ultrasound-guided percutaneous core needle biopsy is a safe and effective method for diagnosing PGILs.
• 18 F-FDG PET-CT enhances the localization of lymphoma lesions, improving biopsy accuracy.
• Minimally invasive techniques can reduce the need for surgical interventions, thereby decreasing complication risks.
• Combining imaging modalities may lead to faster initiation of chemotherapy, positively impacting overall survival.

Clinical Implications

The findings support the use of 18 F-FDG PET-CT in conjunction with ultrasound-guided biopsies as a standard practice for diagnosing PGILs. This approach can help avoid unnecessary surgeries and expedite treatment, ultimately improving patient outcomes.

Conclusion

The study validates the efficacy of combining 18 F-FDG PET-CT with ultrasound-guided core needle biopsy for diagnosing PGILs, highlighting its potential to enhance diagnostic accuracy and patient care.

References

1. European Radiology, 2022 -- Role of Dual-Tracer PET/CT with [68Ga]FAPI-04 and [18F]FDG in the Initial Assessment of Gastric Cancer
2. The ASCO Post, 2013 -- PET/CT Superior to Bone Marrow Biopsy for Diagnosis, Prognosis in Lymphoma
3. European Radiology, 2024 -- Key Imaging Guidelines for Lymphoma: Recommendations from the European Society of Oncologic Imaging
4. European Radiology, 2024 -- Assessing the Diagnostic Accuracy of [18F]ALF-NOTA-FAPI-04 PET/CT in Gastric Cancer Compared to [18F]FDG PET/CT: A Comparative Analysis
5. SEOM–GOTEL clinical guidelines on diffuse large B-cell lymphoma (update 2025) - PMC
6. European Society of Gastrointestinal Endoscopy, 2025 -- Guidelines for Endoscopic Procedures
7. SEOM–GOTEL clinical guidelines on diffuse large B-cell lymphoma (update 2025) - PMC
8. 25012 390..418